Investment7 Jan 2026, 02:50 pm
JB Chemicals & Pharmaceuticals to Invest Additional Rs. 18 Crores in Wholly-Owned Dubai Subsidiary
AI Summary
JB Chemicals & Pharmaceuticals Ltd. has approved an additional investment of up to Rs. 18 crores in its wholly-owned subsidiary, Unique Pharmaceutical Laboratories, FZE (UPL FZE) at Dubai. The investment is aimed at meeting the operational requirements of UPL FZE. UPL FZE, incorporated in December 2013, is engaged in medicines trading and reported a revenue of AED 627,639 in FY 2024-25. The transaction is at arm's length and does not involve any related party transactions beyond the Company's shareholding in UPL FZE. The investment is likely to be completed within three months and will be in cash.
Key Highlights
- JB Chemicals to invest additional Rs. 18 crores in its Dubai subsidiary, Unique Pharmaceutical Laboratories, FZE
- Investment aimed at meeting operational requirements of the subsidiary
- Subsidiary engaged in medicines trading and reported a revenue of AED 627,639 in FY 2024-25
- Transaction is at arm's length
- Investment likely to be completed within three months